Download Files:
Capecitabine
SKU
HY-B0016-1 g
Category Reference compound
Tags Apoptosis;Cell Cycle/DNA Damage, Apoptosis;DNA/RNA Synthesis;Nucleoside Antimetabolite/Analog, Cancer
$55 – $198
Products Details
Product Description
– Capecitabine is an oral proagent that is converted to its active metabolite, 5-FU, by thymidine phosphorylase.
Web ID
– HY-B0016
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Cancer-programmed cell death
Molecular Formula
– C15H22FN3O6
References
– [1]PharmD CM, et al. Capecitabine: A review. Clinical Therapeutics. 2005 Jan; 27(1): 23-44.|[2]Guichard SM, et al. Gene expression predicts differential capecitabine metabolism, impacting on both pharmacokinetics and antitumour activity. Eur J Cancer. 2008 Jan;44(2):310-7.
CAS Number
– 154361-50-9
Molecular Weight
– 359.35
Compound Purity
– 99.87
SMILES
– O[C@H]1[C@@H](O)[C@H](N2C=C(C(NC(OCCCCC)=O)=NC2=O)F)O[C@@H]1C
Clinical Information
– Launched
Research Area
– Cancer
Solubility
– DMSO : 250 mg/mL (ultrasonic)|H2O : ≥ 33.33 mg/mL
Target
– Apoptosis;DNA/RNA Synthesis;Nucleoside Antimetabolite/Analog
Pathway
– Apoptosis;Cell Cycle/DNA Damage
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.